DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: Dana-Farber Cancer Institute
Collaborators: Susan G. Komen Breast Cancer Foundation|Breast Cancer Research Foundation|Terri Brodeur Breast Cancer Foundation